Papillary thyroid cancer medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Papillary thyroid cancer}}
{{Papillary thyroid cancer}}
{{CMG}}; {{AE}} {{Ammu}}
{{CMG}}; {{AE}} {{Sahar}} {{Ammu}}
==Overview==
==Overview==
Patients with papillary thyroid cancer are treated with  radioactive iodine therapy, hormone therapy, and targeted medical therapy.
Patients with papillary thyroid cancer are treated with  radioactive iodine therapy, hormone therapy, and targeted medical therapy.

Revision as of 18:55, 14 August 2019

Papillary thyroid cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Papillary thyroid cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Papillary thyroid cancer medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Papillary thyroid cancer medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Papillary thyroid cancer medical therapy

CDC on Papillary thyroid cancer medical therapy

Papillary thyroid cancer medical therapy in the news

Blogs on Papillary thyroid cancer medical therapy

Directions to Hospitals Treating Papillary thyroid cancer

Risk calculators and risk factors for Papillary thyroid cancer medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Ammu Susheela, M.D. [3]

Overview

Patients with papillary thyroid cancer are treated with radioactive iodine therapy, hormone therapy, and targeted medical therapy.

Medical Therapy

  • Treatment options for papillary thyroid cancer include:[1]
 
 
 
 
 
 
 
 
Papillary thyroid cnacer treatment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Localized or regional tumor
 
 
 
 
Metastatic
 
 
 
 
Recurrent
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Surgery
Total thyroidectomy
Lobectomy
RAI therapy
Thyroid suppression therapy
EBRT
 
 
 
 
 
 
 
 
 
 
 
Surgery ± postoperative RAI therapy
Targeted therapy
EBRT
Chemotherapy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Iodine sensitive
 
 
 
Iodine resistent
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RAI therapy
Thyroid suppression therapy
 
 
 
Thyroid suppression therapy
Targeted therapy
Surgery
EBRT
 
Papillary Thyroid Cancer Treatment Options

Radiation Therapy

  • External beam radiation therapy
  • Intensity modulated radiation therapy

Precision Medicine and Targeted Therapy

  • Sorafenib[2]
  • Lenvatinib

Hormone Therapy

  • Levothyroxine in a dosage of 2.5-3.5 mcg/kg/day is recommended for patients post thyroidectomy.

References

  1. "Thyroid Cancer Treatment (Adult) (PDQ®)–Health Professional Version - National Cancer Institute".
  2. Targetted therapy for thyroid cancer.Cancer.org(2015). http://www.cancer.org/cancer/thyroidcancer/detailedguide/thyroid-cancer-treating-targeted-therapy Accessed on November,4, 2015

Template:WikiDoc Sources